Home/ Stocks/ PRPO

Precipio, Inc. Common Stock

PRPO XNAS

$23.97 +0.51 (+2.17%) ▲ 15-min delayed

Open

$23.49

High

$25.04

Low

$23.34

Volume

62.8K

Market Cap

$41.93M

About Precipio, Inc. Common Stock

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Sector: LABORATORY ANALYTICAL INSTRUMENTS Employees: 71 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$6.71M	$-1,443,000	$-0.81
FY 2025	$24.05M	$-363,000	$-0.23
Q3 2025	$6.77M	$-79,000	$-0.05
Q1 2025	$4.93M	$-884,000	$-0.59

Related Market News

No specific coverage for PRPO yet. Check out our latest market news or earnings calendar.

Get PRPO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Precipio, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.